logo
LS GreenLink Commences Development of Advanced Manufacturing and Port Facility in Chesapeake, Virginia

LS GreenLink Commences Development of Advanced Manufacturing and Port Facility in Chesapeake, Virginia

Business Wire29-04-2025

CHESAPEAKE, Va.--(BUSINESS WIRE)-- LS GreenLink USA, Inc. ("LS GreenLink"), a subsidiary of LS Cable & System Ltd. ('LS Cable & System'), today officially commenced construction on its state-of-the-art manufacturing and port facility in Chesapeake, Virginia. This significant project represents a major advancement in bolstering global energy infrastructure, with the initial phase representing an investment exceeding $681 million and the creation of more than 330 new jobs in the region.
The initial phase of the development will encompass a 750,000 sq. ft. advanced manufacturing plant, a 660-foot VCV (Vertical Continuous Vulcanization) tower, and a dedicated pier, all designed to enhance the production, handling, and global delivery of HVDC (high-voltage direct current) submarine cables critical to modern energy infrastructure. The 660-foot VCV tower is projected to be the tallest structure in the Commonwealth of Virginia and the tallest structure between Philadelphia, Pennsylvania, and Charlotte, North Carolina, underscoring the facility's significant contribution to the regional skyline.
Bon-Kyu Koo, President & CEO of LS Cable & System, said, 'This groundbreaking marks a monumental step forward for LS Cable & System in fulfilling our global vision for energy infrastructure. By investing in cutting-edge manufacturing facilities like the one in Chesapeake, Virginia, we not only strengthen our competitive position in the global market but also play a crucial role in providing innovative solutions to meet the world's growing energy demands. The success of this project will enhance our global footprint and contribute significantly to the advancement of sustainable energy systems worldwide.'
Gisu Kim, Regional President of North America at LS Cable & System, emphasized the significance of the new facility, stating, 'The development of this advanced manufacturing facility highlights LS Cable & System's continued commitment to the United States. This project not only strengthens our global production capabilities but also contributes directly to local economic growth and the advancement of the region's energy infrastructure. We are proud to support the communities where we operate and look forward to the positive impact this facility will have across the broader energy sector.'
'This groundbreaking event represents far more than the launch of a construction project - it marks the start of a long-term investment in innovation, sustainability, and energy resilience,' said Patrick Y. Shim, Managing Director of LS GreenLink USA, Inc. 'With this facility, LS GreenLink is laying the foundation for leadership in advanced manufacturing while reinforcing the global energy infrastructure that powers industries and communities worldwide.'
Virginia Governor Glenn Youngkin remarked, 'The commencement of this facility in Chesapeake is a proud moment for Virginia. This investment strengthens our leadership in innovation, energy, and manufacturing while creating hundreds of new jobs. LS GreenLink's commitment to developing advanced energy infrastructure here exemplifies the innovative and impactful growth we are seeing across the Commonwealth.'
U.S. Senator Mark Warner stated, 'I've been proud to support this project, and am thrilled to finally celebrate the groundbreaking of this manufacturing and port facility. This investment by LS GreenLink will be tremendous for Chesapeake, and for Virginia as a whole, bringing high-quality, good-paying jobs to the region while continuing the Commonwealth's leadership in energy investment and infrastructure.'
'I'm thrilled to be breaking ground with LS GreenLink on its Hampton Roads cable manufacturing and pier facility, and I'm proud that this project was facilitated by tax credits in the Inflation Reduction Act that I fought to pass,' said U.S. Senator Kaine. 'This facility will create hundreds of high-quality, good-paying jobs, boost the region's economy, and affirm Virginia's global status as a clean energy hub.'
U.S. Representative Bobby Scott shared, 'I am proud to welcome LS GreenLink to Virginia's Third Congressional District. Hampton Roads is a leader in offshore wind production and this subsea cable facility is an important piece of the domestic offshore wind supply chain. Thanks to the Inflation Reduction Act, LS GreenLink is utilizing tax credits for projects that expand clean energy. The manufacturing tax credits, which I spearheaded with my colleagues, are bringing high-paying jobs to our local economy and I look forward to seeing the completed facility.'
'This groundbreaking ceremony represents not just a significant investment in the City of Chesapeake but also for the Hampton Roads community,' said Chesapeake City Mayor Rick West. 'This investment represents a huge step for the region's clean energy and offshore wind industries. LS GreenLink's decision to locate in Chesapeake proves the City's and region's commitment to clean, renewable energy. We look forward to future investment from LS and a continued partnership with South Korea.'
Doug Smith, President & CEO of Hampton Roads Alliance, commented, 'The Hampton Roads region has long been recognized for its strong maritime and manufacturing capabilities. This significant investment from LS GreenLink in Virginia not only enhances our regional economy but further establishes Hampton Roads as a hub for innovation and advanced manufacturing in the energy sector. We are excited to support LS GreenLink in this endeavor.'
Finally, David White, Executive Director of Virginia Maritime Association, added, 'The development of this advanced manufacturing facility in Chesapeake aligns with the strategic growth of Virginia's maritime industry. This project will provide critical infrastructure for the global energy supply chain while creating high-quality jobs in the region. We are proud to be part of this exciting development and look forward to its future success.'
The initial phase is expected to be completed by the third quarter of 2027, with the facility fully operational by the first quarter of 2028. Subsequent phases of the project are planned, allowing LS GreenLink to expand its production capacity and technological capabilities in response to evolving global infrastructure requirements.
The groundbreaking ceremony brought together executives from LS GreenLink, elected officials, industry partners, and local community leaders, all of whom expressed their support for the project's positive economic and strategic impact on the region.
About LS Cable & System Ltd.
Founded in 1962, LS Cable & System Ltd. is a global leader in power and communication cables and systems. With over 6,500 employees and 35 subsidiaries in 17 countries, LS Cable & System continues to drive innovation in energy transmission and distribution. For more information, visit www.lscns.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Confused by latest order? How to calculate if your Jackson County assessment is within limits
Confused by latest order? How to calculate if your Jackson County assessment is within limits

Yahoo

timean hour ago

  • Yahoo

Confused by latest order? How to calculate if your Jackson County assessment is within limits

KANSAS CITY, Mo. — Jackson County assessments are showing up in homeowner's mailboxes. Some people may be surprised at the increase after a May order from the State Tax Commission. Some taxpayers may receive tax refunds in June: When payments could arrive That order capped increases in each assessment period at 15% and set 2022 as a starting point for this year's assessments after 2023 assessments were heavily contested. But determining your maximum 2025 assessment is a little bit more complicated than a single multiplication or division. Legislator Sean Smith and Preston Smith (no relation) have been helping homeowners with appeals since assessments skyrocketed in 2023. This week as they went out again they've been getting questions about what the latest State Tax Commission Order and 15% cap really means. 'People look at it and the first thing they see is, I thought it was only going to be a 15% increase and that was the perception. I've probably answered it online 100 times,' Preston Smith said. 'A lot of people are contacting me thinking they only do the 15 percent once, but you have to do it twice,' Legislator Sean Smith explained. To illustrate how it works with the latest rules using 2022 assessments as the starting point, consider a home with a $100,000 assessed value in 2022. To calculate the maximum assessed value in 2023 multiply $100,000 by 1.15 which is $115,000. But then you have to multiply by 115% again to determine the maximum value a home could be assessed at this year. In this example it would be $132,250. The two 15% increases end up yielding a maximum increase of 32.25% during the two assessment periods. 'I would really urge people to do the math themselves to check it, check and really verify,' Preston Smith said. To do that, however, you have to know your home's 2022 assessed value, which according to those who have received this year's assessments, isn't on this year's notices. You can find that historical information online at the Jackson County Parcel Viewer or Ascend Web. If your increase ends up beyond the allowances under the State order or if you simply don't agree with your value, you still can appeal. Appeals have to be filed by July 14. Download WDAF+ for Roku, Fire TV, Apple TV As for seniors, 40,000 are already enrolled in a new tax credit program freezing tax bills. The county says estimated savings are included on notices, but are subject to change. Both Sean and Preston Smith say they are pressing the Assessor's Office for complete assessment data in 2022, 2023 and 2025 to see how much home values increased, and how many of those increases equated to the maximum allowed if no new construction was done under the State Tax Commission Order without a physical inspection. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

H.C. Wainwright Reiterates Buy Rating on Immix Biopharma (IMMX) Following Promising Interim Results from NXC-201 Trial
H.C. Wainwright Reiterates Buy Rating on Immix Biopharma (IMMX) Following Promising Interim Results from NXC-201 Trial

Yahoo

time3 hours ago

  • Yahoo

H.C. Wainwright Reiterates Buy Rating on Immix Biopharma (IMMX) Following Promising Interim Results from NXC-201 Trial

On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a price target of $7.00. The analyst based the rating on the promising interim results from the NEXICART-2 Phase 1/2 clinical trial of NXC-201, presented at the 2025 American Society of Clinical Oncology Annual Meeting (ASCO 2025) in Chicago, Illinois. The trial assessed the efficacy of NXC-201 in patients with relapsed/refractory AL amyloidosis and delivered a 100% response rate, with a considerable portion attaining a complete hematologic response. The analyst reasoned that the absence of hematologic relapse or progression and the rapid mean time to response further highlight NXC-201's potential as a viable treatment. A doctor in a white coat discussing clinical trial results with a patient in an oncology practice. Burns also reasoned that NXC-201 appears to have a favorable safety profile, as no patients experienced severe cytokine release syndrome or neurotoxicity. While he highlighted the need for longer-term follow-up and the small sample size, the analyst stated that the interim results are promising when compared to existing treatments. This condition does not have FDA-approved agents, and there exists a fragmented treatment landscape post-frontline therapy, factors that suggest the notable market opportunity for NXC-201 and support the buy rating for Immix Biopharma, Inc. (NASDAQ:IMMX). Immix Biopharma, Inc. (NASDAQ:IMMX) is a biopharmaceutical company that develops therapies for inflammatory diseases and cancer. While we acknowledge the potential of IMMX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target
Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target

Yahoo

time3 hours ago

  • Yahoo

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target

In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $80.00. The analyst based the rating on the company's strategic developments and promising pipeline. One of the primary reasons behind the rating was the anticipated Phase II data for the oral treatment for hypothalamic obesity (HO). It is expected to deliver notable BMI reduction and has been de-risked, thereby extending the potential of the franchise beyond the current expiration dates. A scientist conducting research in a laboratory, studying a Petri dish with advanced biopharmaceuticals. The analyst stated that management is confident in the weekly subcutaneous (subQ) treatment, which closely aligns with the previously approved setmelanotide, and thus further adds to the positive outlook for Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM). According to Ding, the setmelanotide Phase II open-label trial for Prader-Willi Syndrome can also pave the way for a significant opportunity if successful, even after its previous challenges. Management is focusing on patient starts instead of the immediate revenue post-launch, and this strategy supports the long-term growth prospects, according to the analyst. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a commercial-stage biopharmaceutical company that develops and commercializes therapeutics for the treatment of rare diseases. Its product pipeline includes IMCIVREE (setmelanotide), a precision medicine that treats hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. The company also has other programs, including a preclinical suite of investigational candidates to treat congenital hyperinsulinism and a clinical development program for setmelanotide in other rare MC4R pathway diseases. While we acknowledge the potential of RYTM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store